To speed the drug discovery path, San Diego’s Sanford Burnham Prebys Medical Discovery Institute, or SBP, recently partnered with WARF Therapeutics.
SD 500 recap: Francis deSouza took the helm of San Diego’s DNA tech giant Illumina Inc. in 2016 and he is leading the company on a five-year plan to extend genomics from research labs into doctors’ offices and as consumer products.
INVESTING: Exec Sees Market Turning In Buyers’ Favor
Private equity firm GTCR is betting big on two San Diego executives to lead its newest biotech venture. The Chicago-based firm is launching a new company, Corza Health, with former NuVasive CEO Greg Lucier and GreatCall CFO Brian Berning.
INVEST: Market Confidence Makes A Comeback
San Diego life science stocks largely recovered in the first quarter after taking a beating at the end of last year.
Scripps 47th Annual Mercy Ball raised $2.5 million to help fund the construction of the new state-of-the-art Scripps MD Anderson Cancer Center on the Scripps Mercy Hospital campus.
The San Diego History Center’s 2019 “Makers of San Diego History” event was the most successful in the organization’s history, raising $109,000 for the nonprofit.
H.I.G. Capital, a Miami private equity firm, acquired Carlsbad-based Jenny Craig for an undisclosed amount.
BIOTECH: Co. Employs Deep Learning, AI and Extensive Image Data
CureMetrix recently got the U.S. Food and Drug Administration’s blessing to market software that flags which mammograms raise suspicions of breast cancer.
Charles River Laboratories, among the firms playing niche roles in drug development, plans to close its San Diego site and lay off 24 employees.
Born in Turkey, Zeynep Ilgaz and her husband came to San Diego in 1998 to earn their master’s degrees, and they founded Confirm BioSciences in 2008.
SDC, a San Diego-based cannabis consumer product goods company, has been acquired for $27 million by Next Green Wave, headquartered in Canada. According to a news release, the company has been rebranded as WeareSDC and, as part of the transaction all members of the SDC team will lead the Next Green Wave extraction and manufacturing unit.
Lloyd Sanders, previously with Myriad Genetics, has joined Epic Sciences as CEO.
FINANCE: Platform Tackles Enzyme Mutations That Hinder Cancer Treatments
Drugmaker Turning Point Therapeutics — taking aim at drug-resistant cancers — recently filed paperwork calling for a $100 million initial public offering.
Biolinq hauled in another $4.75 million to bring its series A round to $15 million, the glucose monitoring company announced March 28.